目的观察氨溴特罗治疗儿童喘息性疾病的临床疗效。方法 96例患儿随机分为治疗组48例和对照组48例,两组患儿均采用抗感染、止咳、雾化等常规治疗,治疗组在此基础上加用氨溴特罗,观察并比较两组的疗效。结果治疗组在咳嗽、咳痰、喘息、肺部哮鸣音及湿啰音等的消失时间和总治疗时间等方面均短于对照组,差异有统计学意义(P<0.05),未见明显不良反应发生。结论氨溴特罗治疗儿童喘息性疾病安全有效。 Objective To observe the clinical efficacy of ambroxol in the treatment of asthmatic children. Methods 96 cases of children were randomly divided into treatment group 48 cases and control group 48 cases, both groups were used anti-infection, cough, atomization and other conventional treatment, the treatment group on the basis of the use of ambroxol, observation and Compare the curative effect of two groups. Results The treatment group was shorter than the control group in the disappearance time of cough, expectoration, wheezing, lung wheeze and wet rales and the total treatment time, the difference was statistically significant (P <0.05), no significant Adverse reactions occurred. Conclusion Ambroxol is safe and effective in treating asthmatic children with asthma.